BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Razonable RR. Cytomegalovirus infection after liver transplantation: Current concepts and challenges. World J Gastroenterol 2008; 14(31): 4849-4860 [PMID: 18756591 DOI: 10.3748/wjg.14.4849]
URL: https://www.wjgnet.com/1007-9327/full/v14/i31/4849.htm
(0) (0) (7300) (174)
Number Citing Articles
1
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Oriol Bestard, Josep M. Cruzado, Edoardo Melilli, Joan Torras, Josep M. Grinyó, Nuria Lloberas, Helena Colom. Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach. Clinical Pharmacokinetics 2023; 62(6) doi: 10.1007/s40262-023-01237-3
2
Jay A. Fishman, Robin K. Avery. Textbook of Organ Transplantation. 2014;  doi: 10.1002/9781118873434.ch94
3
G. Erwin Buckel, G. Andrea Alba. Dieciséis años de experiencia de trasplante hepático en clínica las condes. Revista Médica Clínica Las Condes 2010; 21(2) doi: 10.1016/S0716-8640(10)70533-2
4
Michael Barry. Single-cycle adenovirus vectors in the current vaccine landscape. Expert Review of Vaccines 2018;  doi: 10.1080/14760584.2018.1419067
5
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases. 2019;  doi: 10.1007/978-1-4939-9034-4_3
6
Narendra S. Choudhary, Sanjiv Saigal, Rajat Shukla, Hardik Kotecha, Neeraj Saraf, Arvinder S. Soin. Current Status of Immunosuppression in Liver Transplantation. Journal of Clinical and Experimental Hepatology 2013; 3(2) doi: 10.1016/j.jceh.2013.04.005
7
R.J. Arasaratnam, I. Tzannou, T. Gray, P.I. Aguayo-Hiraldo, M. Kuvalekar, S. Naik, A. Gaikwad, H. Liu, T. Miloh, J.F. Vera, R.W. Himes, F.M. Munoz, A.M. Leen. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. American Journal of Transplantation 2018; 18(9) doi: 10.1111/ajt.14967
8
Nurettin Dogan, Anna Hüsing-Kabar, Hartmut H. Schmidt, Vito R. Cicinnati, Susanne Beckebaum, Iyad Kabar. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. Journal of International Medical Research 2018; 46(9) doi: 10.1177/0300060518785543
9
Augustine J. Sohn, Hoonbae Jeon, Joseph Ahn. Primary Care of the Liver Transplant Recipient. Primary Care: Clinics in Office Practice 2011; 38(3) doi: 10.1016/j.pop.2011.05.006
10
Sari R. Freedman, Kenneth Saunders, Michael E. Plazak, Bharath R. Ravichandran, Kapil K. Saharia, Brian M. Masters, Tracy Sparkes. Impact of high MELD scores on CMV viremia following liver transplantation. Transplant Infectious Disease 2023; 25(1) doi: 10.1111/tid.14001
11
Murat Aral, Ayfer Bakır, Cemal Çiçek, Elif Tuğçe Güner, Didem Özkan, Muhammed Furkan Kürkçü, Gülşah Ceylan Yağız, Mehmet Morkoç, Ferit Kulalı, Ahmet Kürşad Güneş. Analytical Performance and Inter-Method Agreement of a Laboratory-Developed CMV qPCR Assay in Clinical Plasma Samples. Microorganisms 2026; 14(5) doi: 10.3390/microorganisms14051127
12
Shanna Kowalsky, Ronen Arnon, Roberto Posada. Prevention of cytomegalovirus following solid organ transplantation: A literature review. Pediatric Transplantation 2013; 17(6) doi: 10.1111/petr.12118
13
David Herman, Hyosun Han. Cytomegalovirus in liver transplant recipients. Current Opinion in Organ Transplantation 2017; 22(4) doi: 10.1097/MOT.0000000000000433
14
Yuliang Wang, Yawu Liu, Ruifa Han, Qiang Li, Zhi Yao, Wenyan Niu, Yuhua Yuan, Zhiqin Tang, Zhijun Zhu, Zhongyang Shen. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation. Journal of Gastroenterology and Hepatology 2010; 25(1) doi: 10.1111/j.1440-1746.2009.05966.x
15
T. Coulson, J. Wendon. Réanimation hépatosplanchnique. 2010;  doi: 10.1016/B978-2-8101-0186-3.50004-7
16
Curtis D. Holt, Drew J. Winston. Transplantation of the Liver. 2015;  doi: 10.1016/B978-1-4557-0268-8.00078-6
17
Anita S. Chong, Maria-Luisa Alegre. The impact of infection and tissue damage in solid-organ transplantation. Nature Reviews Immunology 2012; 12(6) doi: 10.1038/nri3215
18
Udayakumar Navaneethan, Preethi G.K. Venkatesh, Jiang Wang. Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD. Journal of Crohn's and Colitis 2011; 5(4) doi: 10.1016/j.crohns.2011.01.010
19
Qingbao Ding, Keyu Wang, Yupeng Li, Peng Peng, Dongyuan Zhang, Donglei Chang, Wentao Wang, Lei Ren, Fang Tang, Ziqiang Li. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation. American Journal of Clinical Oncology 2023; 46(7) doi: 10.1097/COC.0000000000001004
20
P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois. The complex interrelationships between chronic lung and liver disease: a review. Journal of Viral Hepatitis 2010; 17(6) doi: 10.1111/j.1365-2893.2010.01307.x
21
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016;  doi: 10.1007/978-94-007-7745-3_40-1
22
Lee R. Wright, Dennis L. Wright, Sandra K. Weller. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery. Viruses 2022; 14(7) doi: 10.3390/v14071557
23
Rohit Talwani, Bruce L. Gilliam, Charles Howell. Infectious Diseases and the Liver. Clinics in Liver Disease 2011; 15(1) doi: 10.1016/j.cld.2010.09.002
24
C. Camus. Complications infectieuses chez le transplanté hépatique. Réanimation 2014; 23(3) doi: 10.1007/s13546-014-0888-7
25
G.W. Kang, H.L. Hong, I.H. Lee, K.S. Ahn, J.D. Kim, D.L. Choi. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report. Transplantation Proceedings 2016; 48(4) doi: 10.1016/j.transproceed.2016.01.021
26
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016;  doi: 10.1007/978-94-007-7742-2_32-1
27
Stefan G. Hübscher, Andrew D. Clouston. MacSween's Pathology of the Liver. 2012;  doi: 10.1016/B978-0-7020-3398-8.00015-5
28
Fawaz D Alshammari. Association between HPV, CMV, EBV and HS Viruses and Breast Cancer in Saudi Arabia. Journal of Cancer Prevention & Current Research 2017; 7(3) doi: 10.15406/jcpcr.2017.07.00236
29
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients. Boletín Médico del Hospital Infantil de México 2016; 73(1) doi: 10.1016/j.bmhimx.2015.12.006
30
A.C. Guardia-Silva, R.S.B. Stucchi, A.M. Sampaio, A. Milan, S.C.B. Costa, I.F.S.F. Boin. Detection of Cytomegalovirus and Human Herpesvirus-6 DNA in Liver Biopsy Specimens and Their Correlation With Rejection After Liver Transplantation. Transplantation Proceedings 2012; 44(8) doi: 10.1016/j.transproceed.2012.07.027
31
Yumi Aoyama, Seiko Sugiyama, Takenobu Yamamoto. Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions. Pharmaceuticals 2022; 15(7) doi: 10.3390/ph15070797
32
Jihua Feng, Xiaoling Zhu, Xiaowen Zheng, Xiaoxin Luo, Chunling Zhao. Severe dengue fever with life-threatening gastrointestinal hemorrhage in a liver transplant recipient undergoing adjuvant chemotherapy for hepatocellular carcinoma. BMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-13479-0
33
Amir Nasimfar, Ebrahim Sadeghi, Abdolvahab Alborzi, Nariman Sepehrvand, Mazyar Ziyaeyan, Marzieh Jamalidoust, Sayed Ali Malek-Hosseini. The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver Transplantation. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.11987
34
W.C. Palmer, C.B. Taner, A.P. Keaveny, R.E. Nakhleh, J.H. Nguyen, B.G. Rosser. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplantation Proceedings 2018; 50(10) doi: 10.1016/j.transproceed.2018.09.001
35
Kentaro Ushijima, Yukihiro Sanada, Shinya Otomo, Keiko Ogaki, Taiichi Wakiya, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Kiichiro Takadra, Ryosuke Akimoto, Yasuharu Onishi, Yasunaru Sakuma, Koichi Mizuta. Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-10507-3
36
Li Zhuang, Sheng-Jun Xu, Dong Chen, Zhen-Bin Ding, Jing-Yang Gu, Dong-Hua Liu, Yan-Hua Lai, Wei Qiu, Feng Wang, Guang-Sheng Yu, Zi-Qiang Li, Chi-Yu He, Qing-Yang Que, Shu-Sen Zheng, Xiao Xu. Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients. Hepatobiliary & Pancreatic Diseases International 2026; 25(4) doi: 10.1016/j.hbpd.2026.05.006
37
Irmeli Lautenschlager. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transplant International 2009; 22(11) doi: 10.1111/j.1432-2277.2009.00907.x
38
Raymund R. Razonable, Ajit P. Limaye. Transplant Infections. 2016;  doi: 10.1007/978-3-319-28797-3_25
39
John A. Zaia. Clinical Virology. 2016;  doi: 10.1128/9781555819439.ch6
40
Nina Singh, Drew J Winston, Raymund R Razonable, G Marshall Lyon, Fernanda P Silveira, Marilyn M Wagener, Ajit P Limaye. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors. Clinical Infectious Diseases 2021; 73(9) doi: 10.1093/cid/ciaa1051
41
Omar J. BenMarzouk-Hidalgo, José M. Cisneros, Elisa Cordero, Almudena Martín-Peña, Berta Sanchez, Cecilia Martin-Gandul, Miguel A. Gentil, Miguel A. Gomez-Bravo, Ernesto Lage, Pilar Perez-Romero. Therapeutic Effect of the Acquisition of Cytomegalovirus-Specific Immune Response During Preemptive Treatment. Transplantation 2011; 91(8) doi: 10.1097/TP.0b013e3182115ba2
42
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt. Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients. Journal of Clinical Virology 2013; 57(1) doi: 10.1016/j.jcv.2013.01.013
43
Balázs Nemes, György Gámán, Attila Doros. Biliary complications after liver transplantation. Expert Review of Gastroenterology & Hepatology 2015; 9(4) doi: 10.1586/17474124.2015.967761
44
Romil Saxena, M. Isabel Fiel. Practical Hepatic Pathology: a Diagnostic Approach. 2018;  doi: 10.1016/B978-0-323-42873-6.00038-X
45
Leila Jalilsani, Ramin Yaghobi, Bita Geramizadeh, Afsoon Afshari, MohammadHossein Karimi. A New Duplication in 668 to 672 Sites of UL54 Gene in Cytomegalovirus Ganciclovir Resistant Liver Transplanted Patients. Jundishapur Journal of Microbiology 2023; 16(9) doi: 10.5812/jjm-137970
46
Salman Khan, Timothy Sullivan, Mohsin Ali, Dallas Dunn, Gopi Patel, Shirish Huprikar. Low‐dose valganciclovir for cytomegalovirus prophylaxis in intermediate‐risk liver transplantation recipients. Liver Transplantation 2018; 24(5) doi: 10.1002/lt.25047
47
Paulina Cybulska, Andy Ni, Carolina Jimenez-Rivera. Viral Hepatitis: Retrospective Review in a Canadian Pediatric Hospital. ISRN Pediatrics 2011; 2011 doi: 10.5402/2011/182964
48
Marzieh Jamalidoust, Mandana Namayandeh, Gholamreza Pouladfar, Mazyar Ziyaeyan. Post-Liver Transplant Cytomegalovirus (CMV) Reactivation, Graft, and Patient Survival Rates in Iranian Population. Jundishapur Journal of Microbiology 2021; 14(3) doi: 10.5812/jjm.112775
49
Thomas V. Brogan, Francois Aspesberro. Diseases of the Liver in Children. 2014;  doi: 10.1007/978-1-4614-9005-0_24
50
Ekta Gupta, Viniyendra Pamecha, Yogita Verma, Niteen Kumar, Archana Rastogi, Nadeem Hasnian, Ajeet Singh Bhadoria. Pre-Transplant Cytomegalovirus Immunoglobulin G Antibody Levels Could Prevent Severe Cytomegalovirus Infections Post-Transplant in Liver Transplant Recipients: Experience from a Tertiary Care Liver Centre. Indian Journal of Medical Microbiology 2017; 35(4) doi: 10.4103/ijmm.IJMM_17_201
51
Douglas Hunt, Sammy Saab. Zakim and Boyer's Hepatology. 2012;  doi: 10.1016/B978-1-4377-0881-3.00049-8
52
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients. Boletín Médico Del Hospital Infantil de México (English Edition) 2016; 73(1) doi: 10.1016/S2444-3409(16)30012-7
53
Mark Pedersen, Anil Seetharam. Infections After Orthotopic Liver Transplantation. Journal of Clinical and Experimental Hepatology 2014; 4(4) doi: 10.1016/j.jceh.2014.07.004
54
Ângela Carvalho-Gomes, Almudena Cubells, Carmina Pallarés, Francisca Corpas-Burgos, Marina Berenguer, Victoria Aguilera, F. Xavier López-Labrador. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation. Cellular Immunology 2022; 371 doi: 10.1016/j.cellimm.2021.104455
55
Eun-Ki Min, Juhan Lee, Su Jin Jeong, Deok-Gie Kim, Seung Hyuk Yim, Mun Chae Choi, Dong Jin Joo, Myoung Soo Kim, Jae Geun Lee. Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipients. International Journal of Infectious Diseases 2023; 131 doi: 10.1016/j.ijid.2023.04.387
56
Michelle Teodoro Alves, Sandra Simone Vilaça, Lara Carvalho Godoi, Leonides Rezende Júnior, Maria das Graças Carvalho, Franciele de Souza Silva, Flávia Loli Guimarães, Ana Paula Fernandes, Luci Maria SantAna Dusse, Karina Braga Gomes. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy. Clinica Chimica Acta 2014; 431 doi: 10.1016/j.cca.2014.01.039
57
D. Kroy, C. Trautwein. Immunsuppression nach Lebertransplantation. Der Gastroenterologe 2018; 13(3) doi: 10.1007/s11377-018-0252-y
58
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations. Annals of Pharmacotherapy 2023; 57(5) doi: 10.1177/10600280221118959
59
Safa Al-shamma, Mark Fox, Fiona Campbell, Paul Collins, Martin Lombard. Diarrhoea and weight loss in an immunosuppressed patient. Gut 2010; 59(9) doi: 10.1136/gut.2009.198986
60
O. M. Tsiroulnikova, I. V. Zhilkin, D. G. Akhaladze. CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS. Russian Journal of Transplantology and Artificial Organs 2016; 18(1) doi: 10.15825/1995-1191-2016-1-67-77
61
Sara Hafezi-Bakhtiari, Oyedele A. Adeyi. Evaluating and interpreting bile duct changes in liver allograft biopsies. Diagnostic Histopathology 2012; 18(2) doi: 10.1016/j.mpdhp.2011.11.001
62
Yong-Hee Kim. Human Cytomegalovirus Infection in Solid-Organ Transplantation. Journal of Bacteriology and Virology 2015; 45(1) doi: 10.4167/jbv.2015.45.1.11
63
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes. Transplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13898
64
Sang Hoon Han. Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies. Infection & Chemotherapy 2017; 49(3) doi: 10.3947/ic.2017.49.3.161
65
Ramin Raul Ossami Saidy, Stefanie Kollar, Zoltan Czigany, Luca Dittrich, Nathanael Raschzok, Brigitta Globke, Wenzel Schöning, Robert Öllinger, Georg Lurje, Johann Pratschke, Dennis Eurich, Deniz Uluk. Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantation. Transplant Infectious Disease 2024; 26(1) doi: 10.1111/tid.14196
66
Abdulkareem M Albekairy, Mohammad S Shawaqfeh, Shroug H Alharbi, Faisal Almuqbil, Mesfer A Alghamdi, Nataleen A Albekairy, Suhaib M Muflih, Abdulmalik Alkatheri. Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation. Transplant Research and Risk Management 2022;  doi: 10.2147/TRRM.S366213
67
Carlos Cervera, Mercé Gurguí, Carlos Lumbreras. Factores de riesgo de la enfermedad por citomegalovirus en el receptor de un trasplante de órgano sólido. Enfermedades Infecciosas y Microbiología Clínica 2011; 29 doi: 10.1016/S0213-005X(11)70051-9
68
Maddalena Giannella, Michele Bartoletti, Pierluigi Viale. Abdominal Solid Organ Transplantation. 2015;  doi: 10.1007/978-3-319-16997-2_2
69
Raymund R. Razonable, James Y. Findlay, Aisling O'Riordan, Gordon S. Burroughs, Mark R. Ghobrial, Banwari Agarwal, Andrew Davenport, Michael Gropper. Critical care issues in patients after liver transplantation. Liver Transplantation 2011; 17(5) doi: 10.1002/lt.22291
70
Tricia A Bal, Glenn Armstrong, Xiang Y Han. Evaluation of the IMMULITE® 2000 CMV IgM assay. Herpesviridae 2012; 3(1) doi: 10.1186/2042-4280-3-2
71
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017;  doi: 10.1007/978-94-007-7693-7_40
72
Siddharth Sood, Craig Haifer, Lijia Yu, Julie Pavlovic, Paul J. Gow, Robert M. Jones, Kumar Visvanathan, Peter W. Angus, Adam G. Testro. Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation. Liver Transplantation 2015; 21(12) doi: 10.1002/lt.24216
73
J.G. Katsolis, W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, T.A. Gonwa, W.C. Hellinger. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high‐risk patients. Transplant Infectious Disease 2013; 15(2) doi: 10.1111/tid.12050
74
A. Kahraman, K. Herzer. Labordiagnostische Überwachung nach Lebertransplantation. Der Gastroenterologe 2014; 9(2) doi: 10.1007/s11377-013-0836-5
75
Chalermrat Bunchorntavakul, K. Rajender Reddy. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterology Clinics of North America 2020; 49(2) doi: 10.1016/j.gtc.2020.01.008
76
D.J. Winston, F. Saliba, E. Blumberg, M. Abouljoud, J.B. Garcia-Diaz, J.A. Goss, L. Clough, R. Avery, A.P. Limaye, B.G. Ericzon, M. Navasa, R.I. Troisi, H. Chen, S.A. Villano, M.E. Uknis. Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial. American Journal of Transplantation 2012; 12(11) doi: 10.1111/j.1600-6143.2012.04231.x
77
Maristela Pinheiro Freire, Isabel C. V. Soares Oshiro, Patricia Rodrigues Bonazzi, Thais Guimarães, Estela Regina Ramos Figueira, Telésforo Bacchella, Silvia Figueiredo Costa, Luiz Augusto Carneiro D'Albuquerque, Edson Abdala. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: An analysis of the epidemiology, risk factors, and outcomes. Liver Transplantation 2013; 19(9) doi: 10.1002/lt.23682
78
Raymund R. Razonable. Cytomegalovirus infection after liver transplantation. Liver Transplantation 2010; 16(S2) doi: 10.1002/lt.22144
79
Lindsay A. Sobotka, Khalid Mumtaz, Michael R. Wellner, Sean G. Kelly, Lanla F. Conteh, A. James Hanje, Austin Schenk, Ashraf El-Hinnawi, Sylvester Black, Kenneth Washburn, Todd Pesavento, Reem Daloul, Anthony J. Michaels. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis. Annals of Hepatology 2021; 24 doi: 10.1016/j.aohep.2021.100318
80
Anita Verma, Anil Dhawan. Clinical Approach to the Management of Infections before and after Liver Transplantation. OBM Transplantation 2020; 4(02) doi: 10.21926/obm.transplant.2002108
81
Kris V. Kowdley. Netter's Gastroenterology. 2010;  doi: 10.1016/B978-1-4377-0121-0.50248-8
82
Peter D. Yoon, Madhukar S. Patel, Carla F. Murillo Perez, Tommy Ivanics, Marco P.A.W. Claasen, Hala Muaddi, David Wallace, Bettina Hansen, Gonzalo Sapisochin, Yu-Chen Fan. Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis. Canadian Journal of Gastroenterology and Hepatology 2022; 2022 doi: 10.1155/2022/9932631
83
Alyssa K. Mezochow, Douglas E. Schaubel, Eliot G. Peyster, James D. Lewis, David S. Goldberg, Therese Bittermann. Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries. Transplant Infectious Disease 2024; 26(4) doi: 10.1111/tid.14317
84
J.M. Kim, S.J. Kim, J.-W. Joh, M. Shin, E.Y. Kim, J.I. Moon, G.O. Jung, G.-S. Choi, C.H.D. Kwon, S.-K. Lee. Preemptive Therapy in Adult Liver Transplant Recipients in CMV-Endemic Area. Transplantation Proceedings 2010; 42(3) doi: 10.1016/j.transproceed.2010.02.026
85
Mina M. Benjamin, Kevin J. Dasher, James F. Trotter. A Comparison of Outcomes Between OKT3 and Antithymocyte Globulin for Treatment of Steroid-Resistant Rejection in Hepatitis C Liver Transplant Recipients. Transplantation 2014; 97(4) doi: 10.1097/01.TP.0000435701.54019.98
86
Gadi Lalazar, Yaron Ilan. Liver Immunology. 2014;  doi: 10.1007/978-3-319-02096-9_12
87
Matteo Ravaioli, Flavia Neri, Tiziana Lazzarotto, Valentina Rosa Bertuzzo, Paolo Di Gioia, Giacomo Stacchini, Maria Cristina Morelli, Giorgio Ercolani, Matteo Cescon, Angela Chiereghin, Massimo Del Gaudio, Alessandro Cucchetti, Antonio D. Pinna. Immunosuppression Modifications Based on an Immune Response Assay. Transplantation 2015; 99(8) doi: 10.1097/TP.0000000000000650
88
J. Sun, G. Cao, L. Zhang, Y. Zhang, Z. Zhao, J. Hu, Y. Ji. Human Cytomegalovirus (CMV) UL97 D605E Mutation Has a Higher Prevalence in Infants With Primary CMV Infection Compared With Transplant Recipients With CMV Recurrence. Transplantation Proceedings 2012; 44(10) doi: 10.1016/j.transproceed.2012.06.069
89
Sara Gredmark-Russ, Cecilia Söderberg-Nauclér. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence 2012; 3(7) doi: 10.4161/viru.22239
90
Isabel Campos‐Varela, Emily A. Blumberg, Patricia Giorgio, Camille N. Kotton, Fauzi Saliba, Emmanuel Q Wey, Michael Spiro, Dimitri Aristotle Raptis, Federico Villamil. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations. Clinical Transplantation 2022; 36(10) doi: 10.1111/ctr.14631
91
Elizabeth Davis. Equine Internal Medicine. 2018;  doi: 10.1016/B978-0-323-44329-6.00008-5
92
Juan Jose Caston, Luis Castells, Evaristo Varo, Miguel Angel Gomez, Manuel de la Mata, Isabel Campos-Varela, Carlos Lumbreras, Luisa Gonzalez-Dieguez, Joan Fabregat, Ignacio Herrero, Magdalena Salcedo, Gloria Sanchez-Antolín, Julian Torre-Cisneros. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation 2016; 100(3) doi: 10.1097/TP.0000000000000912
93
Non-Neoplastic Diseases of the Liver. 2022;  doi: 10.55418/9781933477183-2
94
Keith W. Hamilton, Emily A. Blumberg. Cytomegalovirus Infection in Liver Transplant Recipients. Infectious Diseases in Clinical Practice 2012; 20(1) doi: 10.1097/IPC.0b013e31823c4817
95
A.M. Sampaio, A.C. Guardia, A. Milan, A.N. Sasaki, P.D. Andrade, S.H.A. Bonon, R.S.B. Stucchi, S.C. Botelho Costa, I.F.S.F. Boin. Co-infection and Clinical Impact of Human Herpesvirus 5 and 6 in Liver Transplantation. Transplantation Proceedings 2012; 44(8) doi: 10.1016/j.transproceed.2012.07.034
96
Marlotte A.A. van der Veer, Negina Nangrahary, Dennis A. Hesselink, Nicole S. Erler, Herold J. Metselaar, Teun van Gelder, Sarwa Darwish Murad. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation. Transplantation 2019; 103(11) doi: 10.1097/TP.0000000000002680
97
. Experimental and Clinical Transplantation 2015; 13(Suppl 1) doi: 10.6002/ect.mesot2014.O26
98
Steve Miller, Henrietta Seet, Yasmeen Khan, Carolyn Wright, Rohan Nadarajah. Comparison of QIAGEN Automated Nucleic Acid Extraction Methods for CMV Quantitative PCR Testing. American Journal of Clinical Pathology 2010; 133(4) doi: 10.1309/AJCPE5VZL1ONZHFJ
99
Zeynep Burcin Yilmaz, Funda Memisoglu, Sami Akbulut. Management of cytomegalovirus infection after liver transplantation. World Journal of Transplantation 2024; 14(3): 93209 doi: 10.5500/wjt.v14.i3.93209
100
Raymund R. Razonable. Emerging Infections 9. 2014;  doi: 10.1128/9781555816803.ch7
101
Suresh B. Boppana, William J. Britt. Human Cytomegaloviruses. Methods in Molecular Biology 2014; 1119 doi: 10.1007/978-1-62703-788-4_17
102
Mark R. Schleiss, Stanley A. Plotkin. Plotkin's Vaccines. 2018;  doi: 10.1016/B978-0-323-35761-6.00016-X
103
Carolin Lackner, Stefan G. Huebscher. Pathologie. Pathologie 2020;  doi: 10.1007/978-3-642-04557-8_13
104
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 2024; 18(2) doi: 10.1007/s12072-023-10629-3
105
Veerendra Sandur, George Therapondos. Problem‐Based Approach to Gastroenterology and Hepatology. 2012;  doi: 10.1002/9781444346381.ch16
106
Julia Engstrom-Melnyk, Pedro L. Rodriguez, Olivier Peraud, Raymond C. Hein. Current and Emerging Technologies for the Diagnosis of Microbial Infections. Methods in Microbiology 2015; 42 doi: 10.1016/bs.mim.2015.04.005
107
Hanlin L. Wang, Christopher D. Anderson, Sean Glasgow, William C. Chapman, Jeffrey S. Crippin, Mathew Augustine, Robert A. Anders, Andres Roma. Pathology of Solid Organ Transplantation. 2009;  doi: 10.1007/978-3-540-79343-4_8
108
André Luís Conde Watanabe, Mateus Silva Feijó, Vinícius Paulo Lima de Menezes, Mayara Regina Galdino-Vasconcelos, Jorge Luis Salinas Caballero, Gustavo Ferreira, Fernando Jorge, Natália Trevizoli, Luiz Gustavo Diaz, Priscila Brizolla de Campos, Gabriel Cajá, Raquel Ullmann, Ana Virgínia Figueira, Tiago Morato, Adriano Moraes, Juan Rafael Branez Pereira, Marcelo Perosa. 500 Consecutive Liver Transplants: The Outcomes of a New Transplantation Program in the Middle West of Brazil. Transplantation Proceedings 2021; 53(1) doi: 10.1016/j.transproceed.2020.06.044
109
Suresh B. Boppana, William J. Britt. Human Cytomegaloviruses. Methods in Molecular Biology 2021; 2244 doi: 10.1007/978-1-0716-1111-1_19
110
Sameh Adel Fayek, Wana Mantipisitkul, Flavia Rasetto, Raghava Munivenkatappa, Rolf N. Barth, Benjamin Philosophe. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB 2010; 12(10) doi: 10.1111/j.1477-2574.2010.00226.x
111
Panagiotis Tryphonopoulos, Debbie Weppler, Michele I. Morris, Cristina Russo, Seigo Nishida, David M. Levi, Jang Moon, Akin Tekin, Gennaro Selvaggi, Eddie Island, Leopoldo Arosemena, Phillip Ruiz, Andreas G. Tzakis. The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center Experience. Transplantation 2011; 92(9) doi: 10.1097/TP.0b013e31822eb1f9
112
Antonio Craxì, Rosa Di Stefano. Sherlock's Diseases of the Liver and Biliary System. 2011;  doi: 10.1002/9781444341294.ch21
113
Zhaoxiang Du, Xingxing Yuan, Jie Yi, Manyu Li, Fangfang Dai, Xin Liu, Ning Liu, Haiqing Sun, Lili Zhang, Yanhua Yu. EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status. Journal of Medical Virology 2026; 98(2) doi: 10.1002/jmv.70837
114
Conrad Rauber, Miriam Awad, Ronald Koschny, Peter Sauer, Arianeb Mehrabi, Philip Gath, Karl-Heinz Weiss, Daniel Nils Gotthardt, Christian Rupp. Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study. Clinics and Research in Hepatology and Gastroenterology 2020; 44(1) doi: 10.1016/j.clinre.2019.05.005
115
Mark R. Schleiss, Stanley A. Plotkin. Vaccines. 2013;  doi: 10.1016/B978-1-4557-0090-5.00046-X
116
Divya Dahiya, Chen‐Fang Lee, Kun‐Ming Chan, Ting‐Jung Wu, Hong‐Shiue Chou, Shin‐Shin Cheng, Wei‐Chen Lee. A short‐term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation. Journal of Hepato-Biliary-Pancreatic Sciences 2011; 18(1) doi: 10.1007/s00534-010-0286-0
117
Ryan H. Rochat, Gail J. Harrison. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2025;  doi: 10.1016/B978-0-323-82763-8.00159-X
118
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi. Textbook of Organ Transplantation. 2014;  doi: 10.1002/9781118873434.ch82
119
Mark H. Kuniholm, Christina M. Parrinello, Kathryn Anastos, Michael Augenbraun, Michael Plankey, Marek Nowicki, Marion Peters, Elizabeth T. Golub, Nell Lurain, Alan L. Landay, Howard D. Strickler, Robert C. Kaplan, Julian W. Tang. Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women. PLoS ONE 2013; 8(4) doi: 10.1371/journal.pone.0061973
120
Christopher J. Damman, George B. McDonald. Transplant Infections. 2016;  doi: 10.1007/978-3-319-28797-3_19
121
A. Verma, K. Palaniswamy, G. Cremonini, N. Heaton, A. Dhawan. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients. Pediatric Transplantation 2017; 21(3) doi: 10.1111/petr.12879
122
Michael S. Forman, Alexandra Valsamakis. Diagnostic Molecular Pathology in Practice. 2011;  doi: 10.1007/978-3-642-19677-5_32
123
Nicolas J. Mueller, Jay A. Fishman. Medical Care of the Liver Transplant Patient. 2012;  doi: 10.1002/9781444398441.ch34
124
Poornima Ramanan, Raymund R Razonable. Cytomegalovirus Infections in Solid Organ Transplantation: A Review. Infection & Chemotherapy 2013; 45(3) doi: 10.3947/ic.2013.45.3.260
125
Ruchi Naik, Walaa Dabbas, Benito Veldepenas, Demetrius Harvell, Fares Eshac, Megan Trivedi, Carlo Minicucci, Mary Hummel, Zheng Jenny Zhang, Lorenzo Gallon, Eleonora Forte. Mechanisms and Determinants of CMV Reactivation in Kidney Transplantation. International Journal of Molecular Sciences 2026; 27(15) doi: 10.3390/ijms27156727
126
Teresa Da Cunha, George Y. Wu. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00088
127
W. Ji, D.-S. Kim, S.-W. Jung, Y.-D. Yu, S.-O. Suh. Pre-emptive Therapy for the Cytomegalovirus Infection After Liver Transplantation in Endemic Areas and Its Optimal Diagnostic Method. Transplantation Proceedings 2013; 45(8) doi: 10.1016/j.transproceed.2013.08.042
128
Songpon Getsuwan, Pornthep Tanpowpong, Chatmanee Lertudomphonwanit, Jariya Chuthapisith, Napapat Butsriphum, Wasuntara Prabpram, Rarong Charoenmuang, Suporn Treepongkaruna. Health-Related Quality of Life in Pediatric Liver Transplant Recipients. Transplantation Proceedings 2021; 53(1) doi: 10.1016/j.transproceed.2020.02.175
129
Dibya Lochan Praharaj, Suprabhat Giri, Anil Chandra Anand, Bipadabhanjan Mallick, Preetam Nath, Saroj Kanta Sahu, Bramhadatta Pattnaik, Subrat Kumar Acharya, Yogesh Kumar Chawla. Viral hepatitis after liver transplantation: A brief overview. World Journal of Virology 2026; 15(1): 114321 doi: 10.5501/wjv.v15.i1.114321
130
IfeanyiChukwu O. Onor, Sarah B. Todd, Erika Meredith, Sebastian D. Perez, Aneesh K. Mehta, G. Marshall Lyon, Stuart J. Knechtle, Steven I. Hanish. Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transplant International 2013; 26(6) doi: 10.1111/tri.12101
131
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplantation Proceedings 2018; 50(10) doi: 10.1016/j.transproceed.2018.05.014
132
Kyoung Yong Lee, Byung-Woo Yoo, Sung Soo Ahn, William Han Bae, Hyukmin Lee, Seung Min Jung, Sang-Won Lee, Yong-Beom Park, Jason Jungsik Song, Juliet V Spencer. Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0181590
133
Antoni Rimola, Miquel Navasa. Evidence‐Based Gastroenterology and Hepatology. 2010;  doi: 10.1002/9781444314403.ch43
134
Elizabeth G. Davis, David E. Freeman, Joanne Hardy. Equine Infectious Diseases. 2014;  doi: 10.1016/B978-1-4557-0891-8.00001-4
135
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019;  doi: 10.1007/978-3-319-96400-3_34
136
M. Isabel Fiel, Thomas Schiano. Acute cellular rejection and its sequelae developing in a 42‐year‐old man after liver transplantation†. Hepatology 2009; 50(2) doi: 10.1002/hep.23161
137
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted children. World Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
138
Raymund R Razonable. Immune-Based Therapies for Cytomegalovirus Infection. Immunotherapy 2010; 2(1) doi: 10.2217/imt.09.82
139
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
140
M. Papachristou, A. Fylaktou, M. Daoudaki, E. Cholongitas, T. Karampatakis, A. Anastasiou, G. Chatzika, F. Makrovasili, L. Vagiotas, K. Karakasi, I. Fouzas. Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation. Transplantation Proceedings 2019; 51(2) doi: 10.1016/j.transproceed.2019.01.074
141
Masami Minemura, Kazuto Tajiri, Yukihiro Shimizu. Liver involvement in systemic infection. World Journal of Hepatology 2014; 6(9): 632-642 doi: 10.4254/wjh.v6.i9.632
142
Gary C. Kanel. Atlas of Liver Pathology. 2024;  doi: 10.1016/B978-0-323-82533-7.00013-2
143
W. Gaya Shivega, Ali Olyaei, Madelaine A. Hack, Pushpa Neppala, George Zak, Alexandra Bolognese, C. Kristian Enestvedt, Erin Maynard, Willscott E. Naugler, David L. Scott, Oren Shaked, Elizabeth Swanson, Lynne Srasfeld, David C. Woodland, Christopher R. Connelly. The current status of CMV prophylaxis and treatment in liver transplant recipients: A single center study. Journal of Liver Transplantation 2025; 20 doi: 10.1016/j.liver.2025.100299
144
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017;  doi: 10.1007/978-94-007-7675-3_32
145
Christina B. Planitzer, Marcus D. Saemann, Hartwig Gajek, Maria R. Farcet, Thomas R. Kreil. Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin Preparations. Transplantation 2011; 92(3) doi: 10.1097/TP.0b013e318224115e
146
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan, Martina Sterneck. Selection and use of immunosuppressive therapies after liver transplantation: current German practice. Clinical Transplantation 2016; 30(5) doi: 10.1111/ctr.12708
147
Ann-Kristin Traska, Tobias Max Nowacki, Richard Vollenberg, Florian Rennebaum, Jörn Arne Meier, Tina Schomacher, Sara Noemi Reinartz Groba, Julia Fischer, Jonel Trebicka, Phil-Robin Tepasse. Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients. Cells 2024; 13(9) doi: 10.3390/cells13090741
148
Jackrapong Bruminhent, Raymund R Razonable. Management of cytomegalovirus infection and disease in liver transplant recipients. World Journal of Hepatology 2014; 6(6): 370-383 doi: 10.4254/wjh.v6.i6.370
149
Chian Yong Low, Seyed Mohammadmehdi Hosseini‐Moghaddam, Coleman Rotstein, Eberhard L. Renner, Shahid Husain. The effect of different immunoprophylaxis regimens on post‐transplant cytomegalovirus (CMV) infection in CMV‐seropositive liver transplant recipients. Transplant Infectious Disease 2017; 19(5) doi: 10.1111/tid.12736
150
Raymund Rabe Razonable. Management of Cytomegalovirus Infection After Renal Transplantation. Infectious Diseases in Clinical Practice 2009; 17(4) doi: 10.1097/IPC.0b013e31819b8d27
151
Omar Jesus BenMarzouk-Hidalgo, Elisa Cordero, Almudena Martín-Peña, Elena García-Prado, Miguel Angel Gentil, Miguel Angel Gomez-Bravo, Lydia Barrera-Pulido, Jose Miguel Cisneros, Pilar Perez-Romero. Prevention of cytomegalovirus disease using preemptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection. Antiviral Therapy 2009; 14(5) doi: 10.1177/135965350901400509
152
Siroj Dejhansathit, Adam Michael Miller, Attaya Suvannasankha. Multiple ‘doughnut’ granulomas in a liver transplant patient with CMV reactivation. BMJ Case Reports 2018; 11(1) doi: 10.1136/bcr-2018-227252
153
S. M. Miescher, T. M. Huber, M. Kühne, P. Lieby, D. R. Snydman, J. L. Vensak, M. Berger. In vitroevaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulins. Vox Sanguinis 2015; 109(1) doi: 10.1111/vox.12246
154
Yuanyi Mang, Yang Gao, Yan Yang, Mei Dong, Qian Yang, Hong Li, Jianghua Ran, Li Li, Jun Ma, Guoyu Chen, Bin Yang, Ying Xie, Yunsong Wu, Yingpeng Zhao, Shengning Zhang. Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case Series. Transplantation Direct 2024; 10(4) doi: 10.1097/TXD.0000000000001598
155
Katherine Quinn Newman Hudson, Kelli W. Williams. With Great Power Comes Great Responsibility. Immunology and Allergy Clinics of North America 2026; 46(4) doi: 10.1016/j.iac.2026.06.012
156
Marta Bodro, Núria Sabé, Laura Lladó, Carme Baliellas, Jordi Niubó, Jose Castellote, Joan Fabregat, Antoni Rafecas, Jordi Carratalà. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transplantation 2012; 18(9) doi: 10.1002/lt.23460
157
A. Milan, A.M. Sampaio, A.C. Guardia, C.R. Pavan, P.D. Andrade, S.H.A. Bonon, S.C.B. Costa, E. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi. Monitoring and Detection of Cytomegalovirus in Liver Transplant Recipients. Transplantation Proceedings 2011; 43(4) doi: 10.1016/j.transproceed.2011.02.031
158
W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, W.C. Hellinger. Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk Recipients. American Journal of Transplantation 2011; 11(10) doi: 10.1111/j.1600-6143.2011.03618.x
159
Blanca C Lizaola-Mayo, Eduardo A Rodriguez. Cytomegalovirus infection after liver transplantation. World Journal of Transplantation 2020; 10(7): 183-190 doi: 10.5500/wjt.v10.i7.183
160
Kathleen M. Doss, Catherine E. Kling, Madeleine R. Heldman, Nina Singh, Marilyn Wagener, Robert M. Rakita, Cynthia E. Fisher, Ajit P. Limaye. Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR). Transplant Infectious Disease 2023; 25(2) doi: 10.1111/tid.14015
161
Wendelyn Bosch, Michael G. Heckman, Surakit Pungpapong, Nancy N. Diehl, Jefree A. Shalev, Walter C. Hellinger. Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation. Transplantation 2012; 93(7) doi: 10.1097/TP.0b013e3182472876
162
Alyson N. Fox, Robert S. Brown. Yamada' s Textbook of Gastroenterology. 2015;  doi: 10.1002/9781118512074.ch108
163
Wojciech Błogowski. Facial transplantation as an option in reconstructive surgery: no mountains too high?. ANZ Journal of Surgery 2009; 79(12) doi: 10.1111/j.1445-2197.2009.05140.x
164
Joachim Denner, Annette Mankertz. Porcine Circoviruses and Xenotransplantation. Viruses 2017; 9(4) doi: 10.3390/v9040083
165
Romil Saxena, Swan N. Thung. Practical Hepatic Pathology: A Diagnostic Approach. 2011;  doi: 10.1016/B978-0-443-06803-4.00042-3
166
Prem N. Patel, Ahmed M. Alkaliby, Mitul C. Mehta, Angeline L. Wang. CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases. Allergy, Asthma & Clinical Immunology 2023; 19(1) doi: 10.1186/s13223-023-00817-z
167
Anne M. Larson, George B. McDonald. Transplant Infections. 2016;  doi: 10.1007/978-3-319-28797-3_36
168
Timothy M. Schmitt, Melissa Phillips, Robert G. Sawyer, Patrick Northup, Klaus D. Hagspiel, Timothy L. Pruett, Hugo J. R. Bonatti. Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection Following Liver Transplantation. Digestive Diseases and Sciences 2010; 55(11) doi: 10.1007/s10620-010-1149-x
169
Manav Wadhawan, Subash Gupta, Neerav Goyal, Karisangal R. Vasudevan, Kausar Makki, Reetika Dawar, Raman Sardana, Nand Lal, Ajay Kumar. Cytomegalovirus infection: Its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: A single-center experience. Liver Transplantation 2012; 18(12) doi: 10.1002/lt.23540
170
Amy W. Liu, Kamonwan Jutivorakool, Cynthia E. Fisher, Robert M. Rakita, Jorge D. Reyes, Renuka B. Bhattacharya, Keith R. Jerome, Ajit P. Limaye. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients. Transplantation 2018; 102(4) doi: 10.1097/TP.0000000000002029
171
Richard R Watkins, Tracy L Lemonovich, Raymund R Razonable. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Review of Clinical Immunology 2012; 8(4) doi: 10.1586/eci.12.25
172
Jasmine Riviere Marcelin, Elena Beam, Raymund R Razonable. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World Journal of Gastroenterology 2014; 20(31): 10658-10667 doi: 10.3748/wjg.v20.i31.10658
173
Yuval Ishay, Yaron Ilan. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_15
174
Yongbo Liu, Bingran Wang, Di Sun, Aiwei Zhou, Zimeng Cai, Tao Zhou, Sen Yang, Qi Pan, Yunmu Gao, Jiaqi Song, Zhipeng Zong, Wanglong Xiao, Hongyuan Liu, Taihua Yang, Zhicong Zhao, Yi Luo, Jianjun Zhang, Jianchen Fang, Zhenzhen Zhan, Linrong Lu, Yuan Liu, Qiang Xia. EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance. Journal of Hepatology 2026;  doi: 10.1016/j.jhep.2026.09.004
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.